Solfit Lifesciences

Solfit is a South Korean biotechnology company focused on developing innovative treatments for muscle-related and metabolic disorders. The company leverages its proprietary Muscle-on-a-chip (MoC) platform, which replicates human muscle tissue environments to enhance the precision of drug discovery and validation. Solfit's research pipeline primarily targets sarcopenia and obesity, aiming to restore muscle function and metabolic health in aging populations. By combining bio-convergence technology with pharmaceutical expertise, the company seeks to provide effective solutions for conditions with high unmet medical needs. The firm was founded as a spin-off from the Korea Research Institute of Bioscience and Biotechnology (KRIBB).